Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 5 Neoplasms 3 Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Stomach Neoplasms 1 Seizures 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Neoplasm Metastasis 1 Myofibroma 1 Liver Neoplasms 1 Hematologic Diseases 1 Endobronchial Metastases 1 Encephalocele 1 Ear Neoplasms 1 Cholecystitis 1 Breast Neoplasms 1 Brain Injuries 1

Interventions

Surveys and Questionnaires 1 Saline Solution 1 Ringer's Lactate 1 Remifentanil 1 Oncolytic Virotherapy 1 Ofloxacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ear Neoplasms × Remifentanil × Clear all

NCT02093143 2014-03-20

ENDOTANIL

Centre Hospitalier Universitaire de Besancon

Phase 3 Completed

Ear Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡